Abstract
HIV Associated Dementia (HAD) and peripheral neuropathy result from HIV-1 infection and several parameters impact on their initiation and course. These parameters include properties of the virus such as sequence heterogeneity of the envelope protein and virus and host gene expression in infected and uninfected macrophages in HIV infected individuals. The infection of brain cells such as macrophage/microglia may influence the course and duration of HAD through the elaboration of toxic molecules and viral host by-products of infection. Drugs of abuse complicate our interpretation of the resulting pathologies and affect the molecular and biochemical processes involved in HIV-1 infection and its life cycle. Furthermore, abused drugs may modulate the biology and function of macrophage/microglia as well as other cells in brain. Total HIV-1 virus load in the brain may also impact the clinical consequences of infection. Although specific strains of HIV-1 may inflict HAD by interactions at the molecular level, other mechanisms may operate in the initiation and development of peripheral neuropathy. An important aspect of these studies is the determination of their accuracy, specificity, sensitivity, and reproducibility. We describe important caveats involved in the performance, analysis, and interpretation of the results.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Achim, C. L., Wang, R., Miners, D. K., and Wiley, C. A. Brain Viral Burden in HIV Infection. J. Neuropathol. Exp. Neurol. 53, 284–294, 1994
Anthony JC, Vlahov D, Nelson KE, Cohn S, Astemborski J, and Solomon L, New evidence on intravenous cocaine use and the risk of infection with HIV-I, Am J of Epidemiol, 134, 1175–1189, 1991
Antonioli IM, Baumberger C, Yerly S, and Perrin L. V3 sequences in primary HIV-1 infection. AIDS, 9. 11–17, 1995
Aylward, E.H., Henderer, J.D., McArthur, J.C., et al. Reduced basal ganglia volume in HIV-1 associated dementia complex: results for quantitative neuroimaging. Neurology, 43, 2099–2104, 1993
Beck KD, Valverde J, Alexi T, Poulsen K, Moffat B, Vandlen RA, Rosenthal A. Hefti F: Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 1995; 373: 339–341
Bell, J. E., Busuttil, A., Ironside, J. W., Rebus, s., Donaldson, Y. K., Simmonds, P., and Peutherer, J. F. Human Immunodeficiency Virus and the Brain: Investigation of Virus Load, and Neuropathologic Changes in Pre-AIDS Subjects. J. Inf. Diseases, 168, 818–824, 1993
Berger JR, Kumar M, Kumar A, Fernandez JB, and Levin B: Cerebrospinal fluid dopamine in HIV infection, AIDS, 8, 67–71, 1994
Bockstahler, L. E., Werner, T., Festl, H., Weis, S., Einhaeupl, K. M., Erfle, V., and Brack-Werner, R. Distribution of HIV genomic DNA in brains of AIDS patients. Clin Diagn Virol, 3, 61–72, 1995
Boni, J., Emmerich, B. S., Leib, S. L., Wiestler, O. D., Schupbach, J., and Kleihues, P. PCR identification of HIV-1 DNA sequences in brain tissue of patients with AIDS encephalopathy. Neurology, 43, 1813 1817, 1993
Brack-Werner, R., Kleinschmidt, A., Ludvigsen, A., Meliert, W., Neumann, M., Heiirnann, R., Khim, M. C. L., Bumy, A., Muller-Lantzsch, N., Stavrou, D., and Volker, E. Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines. AIDS, 6, 273–285, 1992
Brew, B. J., Rosenblum, M., Cronin, K, and Price, R. W. AIDS Dementia Complex and HIV-1 Brain Infection: Clinical-Virological Correlations, Ann Neurol, 38, 563–570, 1995
Briant L. Puel J, Wade CM, Leigh Brown AJ, and Guyader M, Protecting HIV databases- Reply, Nature, 378, 243–244, 1995
Briant L, Wade CM, Puel J, Leigh Brown AJ, and Guyader M, Analysis of envelop sequence variants suggests multiple mechanisms of mother-to-child transmission of HIV-1, J Virol, 69, 3778–3788. 1995
Budka,H. et al.(33 authors).HIV-Associated disease of the nervous system: Review of nomenclature and proposal for neuropathology-based terminology. Brain Pathology, 1, 143–152, 1991
Chaisson RE, Bachchetti P, Osmond D, et al, Cocaine use and HIV infection in intravenous drug users in San Francisco, JAMA, 261, 561–565, 1989
Chelley J and Kahn A, RT-PCR and mRNA quantitation, in the polymerase chain reaction, eds. KB Mullis, F Ferré, and RA Gibbs, Birkhauser Press, Boston, 1994, pp. 97–109
Chitwood DD, McCoy CB, Inciardi J, et al, HIV seropositivity of needles from shooting galleries in South Florida, Am J Public Health, 80, 150–152, 1990
Centers for Disease Control and Prevention. Revision of the CDC surveillance case definition of AIDS. JAMA, 258, 1143–1154, 1987
Concha M, Graham NMH, Munoz A, Vlahov D, Royall III, W, Updike M, Nance-Sproson T, Seines OA, and McArthur JC, Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with high prevalence of HIV-I seropositivity, Am J of Epidemiol, 136, 1338–1348, 1992
Cotter, F. E. The role of polymerase chain reaction in pathology. J. Histotechnology, 17, 253–259, 1994
Dal Pan, G.J., McArthur, J.H., Aylward, E., Seines, O.A., Nance-Sproson, T.E., Kumar, A.J., Mell its, E.D., and McArthur, J.C. Patterns of cerebral atrophy in HIV-1-infected individuals: Results of a quantitative MRI analysis. Neurology, 42, 2125–2130, 1992
Delassus S, Cheynier R, and Wain-Hobson S, Non-homogeneous distribution of HIV-1 proviruses in the spleen, J of Virol, 66, 5642–5645, 1992
Eilbot DJ, Peress N, Burger H, et al, HIV-1 in spinal cords of AIDS patients with myelopathy: expression and replication in macrophages, PNAS, 86, 3337–3341, 1989
Epstein LG, Kuiken C, Blumberg BM, Hartman S, Sharer LR, Clement M, and Goudsmit J, HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies, Virol, 180, 583–590, 1991
Felsenstein J, Confidence limits on phylogenies: an approach using bootstrap, Evolution, 39, 783–791, 1985
Fujimura, R. K. and Bockstahler L. E. PCR Method for determining ratios of HIV proviral DNA to cellular genomic DNA in brain tissue of HIV-infected patients. J Vir Method, 55, 309–325, 1995
Goodenow M, Huert T, Saurin W, Kwok S. Sninsky J, and Wain-Hobson S, HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions, J’ of AIDS. 2. 344–352, 1989
Goodenow M, Huert T, Saurin W, Kwok S. Sninsky J, and Wain-Hobson S, HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions, J’ of AIDS. 2. 344–352, 1989
Goodkin K: HIV-related complications of the central nervous system. In: Beckett A, Fernandez F, Goodkin K and McDaniel JS. HIV-related neuropsychiatrie complications and treatments. An AIDS Training Curriculum for Psychiatrists. Commission on AIDS, M. Forstein (Chair), American Psychiatric Association, Washington, DC, 1995, pp. 1–64
Goswami KK, Miller RF, Harrison MJ, Hamel DJ, Daniels RS, and Tedder RS, Expression of HIV-1 in the CSF detected by the PCR and its correlation with CNS disease, AIDS, 5, 797–803, 1991
Grez M, Dietrich U, Balfe P, von Briesen H, Maniar JK, Mahambre G, Delwart EL, Mullins JI, and Waigmann HR, Genetic analysis of HIV-1 and -2 mixed infections in India reveals a recent spread of HIV-1 and HIV-2 from single ancestor for each of these viruses, J Virol, 68, 2161–2168, 1994
Gribskov M and Devereux J, Sequence Analysis Primer, WH Freeman and Co, New York, 1992
Groenink M, Andeweg AC, Fouchier RAM, Broersen S, Van der Jagt RCM, Schuitemaker H, De Goede REY, Bosch ML, Huiseman HG, and Tersmette M, Phenotype associated env gene variation among eight related HIV-1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domain, J Virol, 66, 6175–6180, 1992
Halm BH, Shaw GM, Taylor ME, Redfield RR, Markham PD, Salahuddin SZ, Wonb Staal F, Gallo RC, Parks ES, and Parks WP, Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS, Science, 232, 1548–1553, 1986
Hasegawa M. Kishino H, and Yano T, Dating the human ape splitting by a molecular clock of mitochondrial DNA, J Molec Evol, 22, 160–174, 1985
Higgins DG, Bleasby AJ, and Fuchs R, Clustal V: improved software for multiple sequence alignment, Comput Appl Biosci, 8, 189–191, 1992
Howell RM, Fitzgibbon JE, Noe M, Ren Z, Gocke DJ, Schartzer TA, and Dubin DT, In vivo sequence variation of the HIV-1 env gene: evidence for recombination among variants found in a single individual, AIDS Res and Hum Retrov, 7, 869–876, 1991
Kalisch ML, Baldwin A, Raktham S, Wasi C, Luo C, Schochetman G, Mastro TD, Young N, Vanichseni S, Rübsamen-Waigmann H, von Briesen H, Mullins J, Delwart E, Herring B, Esparza J, Heyward WL, and Osmmanov S, The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand: implications for HIV vaccine trials, AIDS 9, 851–857, 1995
Koob GF, Bloom FE: Cellular and molecular mechanisms of drug dependence. Science 1988; 242: 715723
Korber BTM, Kunstman KJ, Patterson BK, et al, Genetic differences between blood-and brain-derived viral sequences from HIV-1-infected patients: evidence for conserved elements in the V3 region of the envelope protein of brain-derived sequences, J of Virol 68, 7467–7481, 1994
Korber BTM, Learn G, Mullins JI Hahn BH, and Wolinsky SM, Protecting HIV databases, Nature, 378, 242–243, 1995.
Kuiken CL, Goudsmit J, Weiller GF, Armstrong, Hartman S, Portegies P, Dekker J, and Cornelissen M, Differences in HIV-1 V3 sequences from patients with and without AIDS dementia complex, J of Gen Virol, 76, 175–180, 1995
Kwok S, Procedures to minimize PCR-product carry-over, in PCR-protocols and applications- A Laboratory Manual, 1990
Learn G, Korber BTM, Foley B, Hahn BH, Wolinsky SM, and Mullins JI, Maintaining the integrity of human immunodeficiency virus sequence databases, J of Viral, submitted, 1995
Lipton SA, Memantine prevents HIV coat protein-induced neuronal injury in vitro. Neurology, 42, 1403–1405, 1992
Louwagie J, McCutchan F, van der Groen G. et al. Genetic comparison of HIV-1 isolates from Africa. Europe, and North America. AIDS Res Hum Retroviruses, 8, 147–9, 1992
Louwagie J, McCutchan FE, Peeters M. et al. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes, AIDS, 7, 769–80, 1993
Masliah, E. Achim, C. L., Ge, N., De Teresa, R., Terry, R. D., and Wiley, C. A. Spectrum of Human Immunodeficiency Virus-associated Neocortical Damage. Ann Neurol, 32, 321–329, 1992
McCoy CB, Shapshak P, Rivers JE, McCoy HV, Weatherby NL, Chitwood DD, Shah SM, Inciardi JA, McBride DC, and Watters JK, The risks of injection practices and compliance to risk reduction protocols in the prevention of HIV-1 among injecting drug users, J of AIDS, 7, 773–776, 1994
McCutchen FE, Hegerich PA, Brennan TP, Phanuphak P, Singharaj P, Jugsudee A, Berman PW, Gray AM, Fowler AK, and Burke DS, Genetic variants of HIV-1 in Thailand, AIDS Res and Hu Retr, 8, 1887–1895 1992
KcKegney FP, O’Dowd MA, Feiner C, et al, A prospective comparison of neuropsychologic function in HIV-seropositive and seronegative methadone-maintained patients, AIDS, 4, 565–569, 1990
Leitner T, Escanilla D, Marquina S, Wahlberg J, Bronstrom C, Hansson HB, Uhlen M, and Albert J, Biological and molecular characterization of subtype D, G, and A/D recombinant HIV transmission in Sweden, Virology, 209, 136–146, 1995
McNearney T, Westervelt P, Thielan BJ, Trowbridge DB, Garcia J, Whittier R, and Ratner L, Limited sequence heterogeneity among biologically distinct HIV-1 isolates from individuals involved in a clustered infectious outbreak, PNAS, 87, 1917–1921, 1990
Meyerhans A, Cheynier R, Albert J, Seth M, Kwok S, Sninsky J, Morfeldt-Mânson L, Asjö, and Wain-Hobson S, Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations, Cell, 58, 901–910, 1989
Meyerhans A, Vartanian JP, and Wain-Hobson S, DNA recombination during PCR, Nucleic Acids Res, 18, 1687–1691, 1990.
Mildvan D, Machado SG, Wilets, I, Grossberg SE: Endogenous interferon and triglyceride concentrations to assess response to zidovudine in AIDS and advanced AIDS-related complex. Lancet 1992; 339: 453456.
Myers G, Berzofsky JA, Korber B, Smith RF, Pavlakis GN. Human retroviruses and AIDS. Los Alamos, NM: Dept. of Theoretical Biology and Biophysics. Los Alamos National Laboratory, 1993
Myers G and Korber B, The Future of HIV, in The Evolutionary Biology of Viruses, ed. S.S. Morse, Raven Press, Ltd., New York, 1994, Chapter 10, pp. 211–232.
Monken CE, Wu B, and Srinivasan A, High resolution analysis of HIV-1 quasispecies in the brain, AIDS, 9, 345–349, 1995
Monken CE, Wu B, and Srinivasan A, High resolution analysis of HIV-1 quasispecies in the brain, AIDS, 9, 345–349, 1995
Monken CE, Wu B, and Srinivasan A, High resolution analysis of HIV-1 quasispecies in the brain, AIDS, 9, 345–349, 1995
Palmer DL, Hjelle BL, Wiley CA, Allen S, Wachsman W, Mills RG, Davis LE, and Merlin TL, HIV-1 infection despite immediate combination antiviral therapy after infusion of contaminated white cells, Am J of Med, 97, 289–295, 1994
Pang, S., Koyanagi, Y., Miles, S., Wiley, C., Vinters, H. V., and Chen I. S. Y. High levels of unintegrated HIV-1 DNA in brain tissue of AIDs dementia patients, Nature, 343, 85–89, 1990
Pang S, Vinters HV, Akashi T, O’Brien WA, and Chen ISY, HIV-1 Env sequence variation in brain tissue of patients with AIDS-related neurologic disease, J of AIDS, 4, 1082–1092, 1991
Pert, C. B., Ruff, M. R., Ruscetti, F., Farrar, W. L., and Hill, J. M. HIV Receptor in Brain and Deduced Peptides That Block Viral Infectivity. in Psychological, Neuropsychiatric, and Substance Abuse Aspects of AIDS. Bridge, T. P. et al. (eds) Raven Press, New York, 1988; pp 73–83
Petito, C. K., Cho, E-S., Lemann, W., Navia, B.A., and Price, R. W. Neuropathology of Acquired Immunodeficiency Syndrome (AIDS): Autopsy Review. J Neuropathol Exp Neurol, 45, 635–646, 1986
Petito CK and Roberts B, Evidence of apoptotic cell death in HIV encephalitis, Am J of Pathol, 146, 1121–1130, 1995
Pieniazek D, Janini LM, Ramos A, Tanuri A, Schechter M, Peralta JM, Vicente ACP, Pieniazek NJ, Schochetman G, and Rayfield MA, HIV-1 patients may harbor viruses of different phylogenetic subtypes: implications for the evolution of the HIV/AIDS pandemic, Emerging Infect Dis, 1, 86–88, 1995
Power C, McArthur JC, Johnson RT, Griffin DE, Glass JD, Dewey R, and Chesebro B. Distinct HIV-1 env sequences are associated with neurotropism and neurovirulence, in HIV and Dementia, eds. MBA Oldstone and L Vitkovic (1995) Cur Topics in Microb and Immunol, 202, pp.89–104
Power C, McArthur JC, Johnson RT, Griffin DE, Glass JD, Perryman S, and Chesebro B, Demented and nondemented patients with /AIDS differ in brain-derived HIV-1, envelope sequences, J of Virology, 68, 4643–4649, 1994
Presley LA and Budowle B, The Application of PCR-based technologies to forensic analysis, in PCR Technology Current Innovations, ed. HG Griffin and AM Griffin, CRC Press, Boca Raton, 1994, pp. 259–276
Ratner L, Haseltine W, Petarca R, Livak KJ, Starcich B, Josephs SF, Doran ER, Rafalski JA, Whitwhoen EA, Baumeister K, Ivanoff L, Petteway SR, Pearson ML, Lautenberger JA, Papas TS, Ghrayeb J, Chang NT, Gallo RC, and Wong-Staal F, Complete nucleotide sequence of the AIDS virus HTLV-III, Nature, 313, 277–285, 1985
Resnick L, Berger JR, Shapshak P, Tourtellotte WW: Early penetration of the blood-brain-barrier by HTLV-II1/LAV, Neurology, 38, 9–15, 1988
Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ: Cocaine receptors on dopamine transporters are related to self administration of cocaine. Science 1987; 237: 1219–1223.
Robertson DL, Hahn BH, and Sharp PM, Recombination in AIDS viruses, J of Molec Evol, 40, 249–259, 1995
Robertson DL, Sharp PM, McCutchan FE, and Hahn BH. Recombination in HIV-1, Nature, 3374, 124–126, 1995
Saag MS, Hahn BH, Gibbons J, Li Y, Parks E, Parks WP, and Shaw GM, Extensive variation of HIV-1 in vivo, Science, 334, 440–444, 1989
Sabino EC, Shpaer EG, Morgado MG, Mullins JI, and Mayer A, The identification of HIV-1 envelope genes recombinant between subtypes B and F, in two epidemiologically linked individuals from Brazil, J of Virology, 68. 6340–6346, 1995
Saitou N and Nei M, The neighbor-joining method: a new method for reconstructing phylogenetic trees, Mol Biol Evol, 4, 406–425, 1987
Saksena NK, Dwyer D, and Barré-Sinoussi F, A “sentinel” technique for monitoring viral aerosol contamination, J of Infect Dis, 164, 1021–1022, 1991
Sala M, Zambruno G, Vartanian JP, Marconi A, Bertazzoni U, and Wain—Hobson S, Spatial discontinuities in HIV-1 quasispecies derived from epidermal Langerhans cells of a patient with AIDS and evidence for double infection, J of Virol, 68, 5280–5283, 1994
Sanchez-Ramos JR, Neurological Emergencies related to drugs of dependence, in Urgent and Emergent Neurology, ed. WJ Wiener, Futura Press, NY, 1995, pp. 487–507
Saphier D: Central nervous system effects of interferon-a in man and animals. Presented at the Psychoneuroimmunology Research Society Meeting. 11/16/94–11/20/94, Key Biscayne, FL
Shah SM, Shapshak P, Rivers JE, Weatherby NL, Xin KQ, Stewart RV, Chitwood DD, Page JB, Mash DC, Vlahov D, and McCoy CB, Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: preliminary laboratory results, J of AIDS, in press, 1996
Shapshak P, Nagano I, Xin KQ, Bradley W, McCoy CB, Sun NCJ, Stewart NCJ, Yoshioka M, Petito C. Goodkin K, Douyon R, Srivastava AK, Crandall KA, HIV-1 heterogeneity and cytokines: neuropathogenesis, in The Brain Immune Axis and Substance Abuse, B. Sharp, T. Eisenstein, J. Madden, and H. Friedman, eds. Adv. in Exp. Med. And Biol., vol. 373, Chapter 31, pp.225–236, 1995
Shapshak P, Sun N, Resnick L, Hsu M. Tourtellotte WW, Schmid P, Conrad A, M. Fiala, and D. T. Imagawa, The detection of HIV by in situ hybridization. Modern Pathology, 3, 146–153, 1990
Shapshak P, Sun NCJ, Yoshioka M, Shah SM, Schiller PC, Resnick L, and Imagawa DT, Detection of HIV-1 in the CNS: expiant culture, immunocytochemical, and in situ hybridization techniques, AIDS, 6, 915–923, 1992
Shapshak P, Tourtellotte WW, Resnick L, Osborne MA, Schmid P, Lee M, Rubinshtein G, Imagawa DT, Mitsuyasu R, Gottlieb M, Gallo RC: HTLV III can cross the blood brain barrier. The Fourth Colloquium in Biological Sciences, Blood Brain Transfer. Annals of the NY Academy of Sci, 529, 291–294, 1988
Shapshak P, Tourtellotte WW, Wolman M, Verity N, Verity MA, Schmid P, Syndulko K, Bedows E, Boostanfar R, Darvish M, Nakamura S, Tomiyasu U: Search for virus nucleic acid sequences in post-mortem human brain tissue using in situ hybridization technology with cloned probes: Some solutions and results on PML and SSPE tissue. J of Neurosci Res 16: 281–301, 1986
Shapshak P, Yoshioka M, Sun NCJ, and Schiller P, The use of combined immunocytochemistry and in situ hybridization to detect HIV-1 in formalin fixed paraffin embedded brain tissue, Modern Pathology, 5, 649–654, 1992
Shaw, G. M. et al. (14 authors) HTLV-III Infection in Brains of Children and Adults with AIDS Encephalopathy, Science, 227, 177–182, 1985
Silberstein CH, McKegney FP, O’Dowd MA, et al, Aprospective longitudinal study of neuropshychological and psychosocial factors in individuals at risk for HTLV-III/LAV infection in a methadone program: preliminary findings, Int J of Neurosci, 32, 669–676, 1987
Simmonds P Balfe P, Ludlam CA, Bishop JO, and Brown AJL, Analysis of sequence diversity in hypervariable regions of the external glycoprotein of HIV-1, J of Virol, 64, 5840–5850, 1990
Sinclair, E., Gray, F., Ciardi, A., and Scaravilli, F. Immunohistochemical changes and PCR detection of HIV provirus DNA in brains of asymptomatic HIV-positive patients. J. Neuropathol. Exp. Neurol. 1994; 53: 43–50
Singer EJ, Syndulko K, Fahy-Chandon BN, Shapshak P, Resnick L, Schmid P, Conrad AJ. and Tourtellotte WW, Cerebrospinal fluid p24 antigen levels and intrathecal immunoglobulin G synthesis are associated with cognitive disease severity in HIV-1, AIDS, 8, 197–204, 1994.
Sippy BD, Hofman FM. Wallach D. and Hinton DR, Increased expression of TNF-a receptors in the brains of patients with AIDS, J of AIDS, 10, 511–521, 1995
Steuler H, Storch-Hagenlocher B, and Wildemann B, Distinct populations of HIV-1 in blood and CSF, AIDS Res and Hum Retrovir, 8, 53–59, 1992
Stewart RV, Shapshak P, Matthews A, Bradley W, Sun NCJ, Mash DC, Perez M. Shah SM, Yoshioka M, Nagano I, Bitonte RA, Sundar KS, Fiala M, and Arguello JC, Effects of cocaethylene and HIV-1 infection on surface marker expression of macrophages isolated from human brain using antibody coated magnetic beads: a preliminary study, submitted, 1996
Strunnikova N, Ray SC, Lisingston RA, Rubalcaba E, and RP Viscidi, Convergent evolution within the V3 loop domain of HIV type 1 in association with disease progression, J of Virol, 69, 7548–7558, 1995
Swofford DS, PAUP* 4.0 d21, Sinauer Assoc, Sunderland, MA, 1995
Sun NCJ, Shapshak P, Lachant NA, Hsu MY, Sieger L, Schmid P, Beall G, and Imagawa DT: Bone marrow examination in patients with AIDS and AIDS related complex (ARC): morphologic and in situ hybridization studies: Am J of Clin Pathol, 92, 589–594, 1989
Tourtellotte WW, Schmid P, Pick P, Verity N. Martinez S, Shapshak P: Quest for a reliable, valid, and sensitive in situ hybridization procedure to detect viral nucleic acids in the central nervous system. Neurochem Res 12 /6: 565–571, 1987
Tourtellotte WW, Singer E, Syndulko K, Shapshak P, and Resnick L, Intra-blood-brain-barrier IgG synthesis in HIV, in Enzymes as Targets for Drug Design, MG Palfreyman, PP McCann, W Lovenberg, JG Temple, A Sjoerdsma, Merrell Dow Research Institute, Academic Press, San Diego, pp. 211–217, 1990
Tourtellotte WW, Verity N, Schmid P, Martinez S, Shapshak P: Covalent binding of formalin fixed paraffin embedded brain tissue sections to glass slides suitable for in situ hybridization. J Virol Methods 15: 87–99, 1987
Tyor WR, Glass JD, Griffin JW, et al, Cytokine expression in the brain during AIDS, Aim Neurol, 31, 349–360, 1992
Tyor WR, Wesselingh SL, Griffin JW, McArthur JC, and Griffin DE, Unifying hypothesis for the pathogenesis of HIV-associated Dementia Complex, Vacuolar myelopathy, and sensory neuropathy, J of AIDS and Human Retrovirology, 9, 379–388, 1995
Vazeux, R., Lacroix-Ciaudo, C., Blanche, S., Cumont, M-C., Henin, D., Gray, F., Boccon-Gibod, L. and Tardieu, M. Low levels of human immunodeficiency virus replication in the brain tissue of children with severe acquired immunodeficiency syndrome encephalopathy. Am. J. Pathol. 1992; 140: 137–144
Vitkovic L, da Cunha A, and Tyor WR, Cytokine expression and pathogenesis in AIDS brain, in “HIV, AIDS and the Brain”, eds. RW Price and SW Perry, Raven Press Ltd, New York, 1994
Wain-Hobson S, Is antigenic variation of HIV important for AIDS and what might be expected in the future? in The Evolutionary Biology of Viruses, ed. S.S. Morse, Raven Press, Ltd., New York, 1994, Chapter 9, pp. 185–209
Wesselingh SL, Power C, Glass JD, Tyor WR, McArthur JC, Farber JM, Griffin JW, and Griffin DE, Intracerebral cytokine messenger RNA expression in AIDS dementia, Ann Neurol, 33, 576–582, 1993
Wieser B, Peress N, La Neve D, Eilbott DJ, Seidman R, and Burger H, HIV-1 expression in the CNS correlates directly with extent of disease, PNAS, 87, 3997–4001, 1990
Wiley, C. A., Masliah, E., and Achim, C. L. Measurement of CNS HIV burden and its association with neurologic damage. Adv Neuroimmunol 1994; 4: 319–325
Wiley, C. A., Schrier, R. D., Nelson, J. A., Lampert, P. W., and Oldstone, M. B. A. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. USA 1986; 83: 7089–7093
Xin KQ, Ma XH, Crandall KA, Bukawa KH, Ishikasubo Y, Kawamoto S, and Okuda K, Dual infection with HIV-1 Thai subtype B and E, The Lancet, 346, 1372–1995, 1995
Xin KQ, Shapshak P, Kawamoto S, Nagano I, McCoy CB, and Okuda K, Highly divergent env sequences of HIV-1 B subtype with two novel V3 loop motifs detected in an AIDS patient in Miami, AIDS Res and Hu Retrov, Sequ Note, 11, 1139–1141, 1995
Yap EPH, Lo YMO, Fleming KA, and McGee JO’D, False-positives and contamination in PCR, in PCR Technology Current Innovations, ed. HG Griffin and AM Griffin, CRC Press, Boca Raton, 1994, pp. 249–258
Yoshioka M, Bradley WG, Shapshak P, Nagano I, Stewart RV, Xin KQ, Srivastava AK, and Nakamura S. Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases, Adv. in Neuroimm, 5, 335–358, 1995
Yoshioka M, Shapshak P, Nakamura S Nagano I, Nelson SJ, and Kogure K, TNF producing cells in AIDS brain, Neurology, 42 (suppl. 3), 236, 1992
Yoshioka M, Shapshak P, Srivastava AK, Nelson SJ, Bradley WG, Berger JR, Rhodes RH, `Sun NCJ, Stewart RV, and Nakamura, Role of immune activation, interleukin-6 expression and HIV-1 in the pathology of dorsal root ganglia of patients with AIDS, Neurology, 44, 1120–1130, 1994
Yoshioka M, Shapshak P, Sun NCJ, Svenningsson A, Nelson S, Resnick L. Tate L, Ferritin immunoreactivity in microglial nodules in AIDS brain, Acta Neuropathologica, 84, 297–306, 1992
Young LS, The polymerase chain reaction: a new tool for the histopathologist, in Molecular Biology in Histopathology, ed J Crocker, J Wiley Publ, New York, 1994, pp. 39–55
Zhu T, Wang N, Carr A, Wolinsky S, and Ho DD, Evidence for coinfection by multiple strains of HIV-1 subtype B in an acute seroconverter, J of Virol, 69, 1324–1327, 1995
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Plenum Press, New York
About this chapter
Cite this chapter
Shapshak, P. et al. (1996). Hiv-1 Neuropathogenesis and Abused Drugs. In: Friedman, H., Eisenstein, T.K., Madden, J., Sharp, B.M. (eds) AIDS, Drugs of Abuse, and the Neuroimmune Axis. Advances in Experimental Medicine and Biology, vol 402. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0407-4_23
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0407-4_23
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-8038-2
Online ISBN: 978-1-4613-0407-4
eBook Packages: Springer Book Archive